TWiV 938: Clinical update with Dr. Daniel Griffin

In his weekly clinical update Dr. Griffin reviews the public health response to poliovirus in New York, impact of mandatory influenza vaccination, monkeypox in a young infant, health care worker exposure to monkeypox virus, monkeypox testing delays, transmission potential of monkeypox virus, TPOXX trial for monkeypox, detection of SARS-CoV-2 subgenomic mRNA, mucosal IgA against SARS-CoV-2, BNT262b2 against Omicron, awareness and use of SARS-CoV-2 antivirals, comparable outcomes for Bebtelovimab and Nirmatrelvir, and COVID-19 and Alzheimer's disease. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Support MicrobeTV with a Spike t-shirt at Vaccinated.US Research assistant position with Amy Rosenfeld (pdf) Public health response to polio in New York (MMWR) Impact of mandatory influenza vaccination (Cambridge Core) Monkeypox in young infant (MMWR) Health care worker exposure to monkeypox virus (MMWR) Monkeypox testing delays (Cambridge Core) Monkeypox in smallpox vaccinated patient (Emerg Inf Dis) Transmission potential of monkeypox virus (Int J Epidemiol) TPOXX trial for monkeypox (ACTG) SARS-CoV-2 subgenomic mRNA detection (J Inf Dis) Quantitative SARS-CoV-2 subgenomic mRNA for Remdesivir treatment (Clin Inf Dis) Anti-spike mucosal IgA (NEJM) BNT262bs against Omicron sublineages (NEJM) Awareness and use of SARS-CoV-2 antivirals (Clin Inf Dis) Comparable outcomes for Bebtelovimab and Nirmatrelvir treatment (J Inf Dis) COVID-19 and Alzheimer's disease (J Alzheimer's Dis) Dr. Griffin's treatment guide (pdf) Contribute to Floating Doctors fundraiser at PWB Letters read on TWiV 938 Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]